This template was built with Webflow's free Prospero UI Kit. Learn more
About
SCN2A
Research
Join
Blog
GoF Clinical Trial
Contact Registry
Donate
The SCN2A Foundation blog
Elsunersen SCN2A ASO Receives FDA Breakthrough Designation
What Is SCN2A Haploinsufficiency?
Understanding SCN2A Mixed Function Disorders
Understanding SCN2A Gain of Function Disorders
Understanding SCN2A Loss of Function Disorders
New Yale Research Points to Levocarnitine for SCN2A
SCN2A and Autism: Understanding the Connection, the Science, and What Comes Next
Elsunersen ASO for SCN2A: Clinical Trial Shows 77% Seizure Reduction in Children with GOF Mutations
CRISPR Activation for SCN2A: A Guide for Families
SCN2A Symptoms: A Family Guide to What Your Child May Experience
What Is an SCN2A Mutation? A Guide for Families
Understanding an SCN2A Prognosis
What Is a Sodium Channel? A Plain-Language Guide for Families
What Is the SCN2A Gene? A Guide for Families
Unravel BioSciences and The SCN2A Foundation Announce Drug Discovery Collaboration
Understanding SCN2A Related Epilepsy: A Guide for Families
Our Journey with SCN2A LOF: A Story of Resilience and Hope
SCN2A Mutation Types: Understanding the Genetic Variants Behind Neurodevelopmental Disorders
IEP Goals for Autism and Nonverbal Children: A Compassionate Guide for Parents
COMBINEDBrain Biorepository - Currently enrolling SCN2A participants
Nonverbal Autism: Ipad Apps for Teaching Letters and Numbers
The SCN2A Global Contact Registry
PANS, Autoimmune Encephalitis, and Delirium: Part 1
Pharmacogenetics and Pharmacogenomics: what are they and why are they important?
.jpg)
.jpg)
.jpg)
.png)
.png)
